Sai Life is well placed to benefit from the shift toward outsourcing in small molecules, given its integrated capabilities across discovery, development and manufacturing and strong process chemistry expertise, believes the brokerage.
Sai Life is well placed to benefit from the shift toward outsourcing in small molecules, given its integrated capabilities across discovery, development and manufacturing and strong process chemistry expertise, believes the brokerage.
<iframe src="https://hindustansphere.com/embed/cluster/ec1a7e931ebcae24884627318881187cfb6a7448" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Sai Life Sciences Gets 'Buy' Rating As PL Capital Initiates Coverage; Check Target Price"></iframe>
